Reduced cytochrome P450 and increased heme oxygenase in liver during rabbit aflatoxicosis

被引:7
作者
Guerre, P
Larroque, C
Pineau, T
Burgat, V
Galtier, P
机构
[1] INRA,LAB PHARMACOL TOXICOL,F-31931 TOULOUSE,FRANCE
[2] INRA,ENVT,UNITE ASSOCIEE PHYSIOPATHOL & TOXICOL EXPT,F-31076 TOULOUSE,FRANCE
[3] INSERM U128,F-34000 MONTPELLIER,FRANCE
关键词
aflatoxin B1; cytochrome P450; heme oxygenase; liver; rabbit;
D O I
10.1016/0024-3205(96)00172-5
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The administration of aflatoxin B1 (AFB1) in New Zealand rabbit for 5 days at a daily oral dose of 0.05 or 0.1 mg/kg decreased microsomal hepatic cytochrome P450 whereas a dose-dependent increase in the reduced microsomal 420nm absorption occured. The nature of such an absorption was then investigated. Either in vitro incubation of control microsomal proteins with AFB1 up to 800 mu M and NADPH, or primary rabbit hepatocyte cultures exposure to AFB1 up to 30 mu M for 24 to 72h, failed to produce any 420nm absorbing species, suggesting that the 420nm absorption observed in vivo was due to an hemoprotein increase. Chemical reductions of microsomal proteins from AFB1-treated rabbits confirmed this hypothesis. Enzyme activity determinations revealed an increase in both microsomal heme oxygenase and NADPH-cytochrome c reductase activities in AFB1 treated rabbits, suggesting that the 420nm absorption observed in vivo was related to a particular increase in heme oxygenase.
引用
收藏
页码:1883 / 1889
页数:7
相关论文
共 23 条
[1]  
[Anonymous], 1986, CYTOCHROME P 450 STR
[2]  
Bergmeyer H.U., 1963, METHOD ENZYMAT AN, P736
[3]  
BUDAVARI S, 1991, MERCK INDEX, P131
[4]   EXPRESSION OF 5 FORMS OF MICROSOMAL CYTOCHROME-P-450 IN PRIMARY CULTURES OF RABBIT HEPATOCYTES TREATED WITH VARIOUS CLASSES OF INDUCERS [J].
DAUJAT, M ;
PICHARD, L ;
DALET, C ;
LARROQUE, C ;
BONFILS, C ;
POMPON, D ;
LI, D ;
GUZELIAN, PS ;
MAUREL, P .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (21) :3597-3606
[5]   IMPAIRMENT OF DRUG-METABOLISM BY THE LIVER IN EXPERIMENTAL FASCIOLIASIS IN THE RAT [J].
GALTIER, P ;
BATTAGLIA, A ;
MORE, J ;
FRANC, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1983, 35 (11) :729-733
[6]   COMPARATIVE INCIDENCE OF ORAL OCHRATOXICOSIS AND AFLATOXICOSIS ON THE ACTIVITY OF DRUG-METABOLIZING-ENZYMES IN RAT-LIVER [J].
GALTIER, P ;
LARRIEU, G ;
LEBARS, J .
TOXICOLOGY LETTERS, 1984, 23 (03) :341-347
[7]  
GARNER RC, 1979, CHEM CARCINOGENS DNA, V1, P187
[8]   COMPARATIVE-ASSESSMENT OF THE EFFECT OF AFLATOXIN-B1 ON HEPATIC-DYSFUNCTION IN SOME MAMMALIAN AND AVIAN SPECIES [J].
GAWAI, KR ;
VODELA, JK ;
DALVI, PS ;
DALVI, RR .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY, 1992, 101 (02) :415-418
[9]   MECHANISM-BASED INACTIVATION OF HUMAN LIVER MICROSOMAL CYTOCHROME-P-450-IIIA4 BY GESTODENE [J].
GUENGERICH, FP .
CHEMICAL RESEARCH IN TOXICOLOGY, 1990, 3 (04) :363-371
[10]   COMPARATIVE CYTO-PATHOLOGY OF PRIMARY RAT HEPATOCYTE CULTURES EXPOSED TO AFLATOXIN-B1, ACETAMINOPHEN, AND OTHER HEPATOTOXINS [J].
HAYES, MA ;
PICKERING, DB .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1985, 80 (02) :345-356